Gamma-Hydroxybutyric Acid in the Treatment of Alcohol Withdrawal Syndrome in Patients Admitted to Hospital

Acta Medica Austriaca

Volumn 30, Issue 3, 2003, Pages 83-86

  Korninger, Christian ^a,d   Roller, Regina E ^b   Lesch, O M ^c  

^a Dept of Lorenz Bohler Trauma U ^*  (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Anton Proksch Institute   (Austria)

^d Unfallkrankenhaus Lorenz Bohler   (Austria)

Author keywords

Alcohol; Craving; Gamma hydroxybutyric acid; Medical treatment; Withdrawal

Indexed keywords

4 HYDROXYBUTYRIC ACID;

ADULT; AGED; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERANCE; FATIGUE; FEMALE; HEADACHE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; PARESTHESIA; PATIENT; SIDE EFFECT; SWEATING; SYMPTOM; TREMOR; UNREST; URTICARIA; VERTIGO; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; DRUG TOLERANCE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INPATIENTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME; SWEATING; TREMOR;

EID: 0141922088     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Addolorato G, Castelli E, Stefanini GF, Casella G, Caputo F, Marsigli L, Bernardi M, Gasbarrini G: An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol 1996;31:341-345.
2. Addolorato G, Balducci G, Capristo G, Attilia ML, Taggi G, Gasbarrini G, Ceccanti M: Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol-withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcoholism Clin Exp Res 1999; 23:1596-1604.
3. Addolorato G, Caputo F, Capristo E, Bernardi M, Stefanini GF, Gasbarrini G: A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration. Clin Neuropharmacol 1999;22:60-62.
4. Anderson RA, Ritzmann RF, Tabakoff B: Formation of gamma-hydroxybutyrate in brain. J Neurochem 1977;28:633-663).
5. Boening J, Lesch OM, Spanagel R, Wolffgramm J, Narita M, Sinclair D, Mason B, Wiesbeck G: Pharmacological Relapse Prevention in Alcohol Dependence: From Animal Models to Clinical Trials. Alcohol Clin Exp Res 2001;25:127S-131S.
6. Beghe F, Carpanini MT: Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients. Alcohol 2000;20:223-225.
7. Bowles TM, Sommi RW, Amiri M: Successful management of prolonged gamma-hydroxybutyrate and alcohol-withdrawal. Pharmacotherapy 2001;21:254-257.
8. Cash CD: Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 1994;18:291-304.
9. Ceccanti M, Attilia ML, Blum K, Cavaleri G, Franzese A, Sasso GF, Balducci G: Gamma-hydroxybutyric acid vs benzodiazepines: a clinical study in chronic alcoholics. Acta Toxicol Ther 1995;16:231-242.
10. Colombo G, Gessa GL: Gamma-hydroxybutyric acid in alcohol preference, dependence and withdrawal. Addiction Biology 2001;5:389-403.
11. th session (Vienna 20-9 March 2001) Changes in the Scope and Control of Substances
12. Craig K, Gomez HF, McManus JL, Bania TC: Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J Emerg Med 2000;18:65-70.
13. DiBello MG, Gambassi F, Mugnai L, Masini E, Mannaioni PF: Gamma-hydroxybutyric acid induced suppression and prevention of alcohol-withdrawal syndrome and relief of craving in alcohol dependent patients. Alcologia 1995;7:91-116.
14. Fadda F, Colombo G, Mosca G, Gessa GL: Suppression by gamma-hydroxybutyric acid of ethanol withdrawal symptoms in rats. Alcohol Alcohol 1998;24:447-451.
15. Fishbein WN, Bessmann SP: Gamma-hydroxybutyrate in mammalian brain. J Biol Chem 1961;239:357-361.
16. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, Fadda F, Gessa GL: Gamma-hydroxybutyric acid for treatment of alcohol-withdrawal syndrome. Lancet ii 1989;787-789.
17. Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL: Gamma-hydroxybutyric acid in treatment of alcohol dependence: A double-blind study. Alcohol Clin Exp Res 1992;16:673-676.
18. Galloway GP, Frederick SL, Staggers Jr FE, Gonzales M, Stalcup SA, Smith DE: Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997;92:89-96.
19. Gessa GL, Crabai F, Vargiu L, Spano PF: Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action. J Neurochem 1968;15:377-381.
20. Hertling I, Ramskogler K, Riegler A, Walter H, Mader R, Lesch OM: Alkoholverlangen und Rückfallprophylaxe. Wien Klin Wochenschr 2001;113: 717-726.
21. Hertling I, Ramskogler K, Riegler A, Zoghlami A, Walter H, Lesch OM: Entzugsbehandlung von alkoholabhängigen Patienten. Wien Zeitschr Suchtf 2001;24: 41-46.
22. Laborit H: Sodium 4-hydroxybutyrate: Int J Neuropharm 1964;3:433-452.
23. Lejoyeux M, Solomon J, Ades J: Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol 1998;33:563-575.
24. Lovinger DM: Excitotoxicity and alcohol-related brain damage. Alcoholism Clin Exp Res 1993;17:19-27.
25. Mamelak M, Escriu JM, Stokan O: The effects of gamma-hydroxybutyrate on sleep. Biol Psychiatry 1977;12:273-288.
26. Maremanni I, Lamanna F, Tagliamonte A: Long-term therapy using GHB (sodium gamma hydroxybutyrate) for treatment-resistant chronic alcoholics. J Psychoactive Drugs 2001;33:135-142.
27. Moncini M, Masini E, Gambassi F, Mannaioni PF: Gamma-hydroxybutyrate (GHB) and alcohol-related syndromes. Alcohol 2000;20:285-291.
28. Nimmerrichter A, Walter H, Gutierrez-Lobos K, Lesch OM: Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol-withdrawal. Alcohol Alcohol 2002;37:67-73.
29. Ramskogler K, Hertling I, Riegler A, Semler B, Zoghlami A, Walter H, Lesch OM: Mögliche Interaktionen zwischen Ethanol und Pharmaka und deren Bedeutung für die medikamentöse Therapie im Alter. Wien Klin Wochenschr 2001;113:363-370.
30. Rathner G, Dunkel D: Incidence of alcoholism and problem drinking in Austria. Wien Klin Wochenschr 1998;22:356-363.
31. Roth RH: Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain. Biochem Pharmacol 1970;19:3013-3019.
32. Roth RH, Doherty DJ, Walters JR: Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons? Brain Res 1980;189:556-560.
33. Schmidt-Mutter C, Pain L, Sandner G, Gobaille S, Maitre M: The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. Eur J Pharmacol 1998;342:21-27.
34. Walter H, Ramskogler K, Semler B, Lesch OM, Platz W: Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials. J Biomed Sci 2001;8:83-88.
35. Williams D, McBride A: The drug treatment of alcohol-withdrawal symptoms: a systematic review. Alcohol Alcohol 1988;33:103-115.